| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2018-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101898891-B1 |
| titleOfInvention |
Composition for Suppressing Side effects of Apoptosis-inducing Anti-cancer Drugs Using Ginsenoside Compound K |
| abstract |
The present invention discloses the effect of the ginsenoside K inhibiting cytotoxic anticancer side effects such as gastrointestinal disorders, bone marrow dysfunction, liver, kidney, and pancreatic dysfunction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102549447-B1 |
| priorityDate |
2017-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |